Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines

NCT00776438 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Orthomyxovirus Infections
Myxovirus Infection

Interventions

BIOLOGICAL: Inactivated, split-virion, influenza vaccine
BIOLOGICAL: Inactivated, split-virion, influenza vaccine
BIOLOGICAL: Inactivated, split-virion influenza vaccine
BIOLOGICAL: Inactivated, split-virion influenza vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company